NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 13 min 28 sec ago

Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)

Mon, 2018-11-26 01:07
Funding Opportunity PA-19-077 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support early phase translational research that will generate new malaria vaccine candidates suitable for further downstream development and clinical evaluation. This research opportunity encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially P. falciparum and P. vivax.

Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R21 Clinical Trial Optional)

Fri, 2018-11-23 02:47
Funding Opportunity RFA-MH-19-411 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits research grant applications which will: 1) advance measurements of intersectional stigma (multiple stigmatized identities) and examine the mechanisms and pathways by which it is a barrier to HIV testing and linkage to prevention; or 2) develop and test interventions to reduce intersectional stigma and improve the uptake of HIV testing and linkage to ongoing HIV prevention among key populations at substantial risk for HIV infection. RFA-MH-19-412 uses the R01 grant mechanism, and RFA-MH-19-410 uses the R34 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism. Applicants with preliminary data and/or include longitudinal analysis may be appropriate for the R01 mechanism. Applicants proposing to develop and pilot test an intervention should consider using the R34 mechanism.

Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R34 Clinical Trial Required)

Fri, 2018-11-23 02:47
Funding Opportunity RFA-MH-19-410 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits research grant applications which will: 1) advance measurements of intersectional stigma (multiple stigmatized identities) and examine the mechanisms and pathways by which it is a barrier to HIV testing and linkage to prevention; or 2) develop and test interventions to reduce intersectional stigma and improve the uptake of HIV testing and linkage to ongoing HIV prevention among key populations at substantial risk for HIV infection.

Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R01 Clinical Trial Optional)

Fri, 2018-11-23 02:47
Funding Opportunity RFA-MH-19-412 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits research grant applications which will: 1) advance measurements of intersectional stigma (multiple stigmatized identities) and examine the mechanisms and pathways by which it is a barrier to HIV testing and linkage to prevention; or 2) develop and test interventions to reduce intersectional stigma and improve the uptake of HIV testing and linkage to ongoing HIV prevention among key populations at substantial risk for HIV infection.

Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NINDS associated SBIR FOAs

Wed, 2018-11-21 12:48
Notice NOT-NS-19-024 from the NIH Guide for Grants and Contracts

Request for Information (RFI): Soliciting Input on the Draft Strategic Plan for NIH Nutrition Research

Wed, 2018-11-21 12:42
Notice NOT-DK-19-004 from the NIH Guide for Grants and Contracts

Reminder: Annual Reports to the Office of Laboratory Animal Welfare due January 31, 2019

Wed, 2018-11-21 11:46
Notice NOT-OD-19-035 from the NIH Guide for Grants and Contracts

Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed)

Tue, 2018-11-20 12:52
Funding Opportunity RFA-AI-18-057 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate development of safe and effective long-acting drug delivery systems (LA-DDS) for improved, simplified treatment of HIV-1 in children. This FOA invites applicants engaged in the development of existing LA-DDS platforms at early product development stages to perform specific preclinical activities that enable product optimization and accelerated translation to HIV-1 infected children. Collaborative research partnerships with industry are required.

Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071

Tue, 2018-11-20 12:31
Notice NOT-AG-18-046 from the NIH Guide for Grants and Contracts

Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071

Tue, 2018-11-20 12:15
Notice NOT-AG-18-047 from the NIH Guide for Grants and Contracts

Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional)

Tue, 2018-11-20 12:07
Funding Opportunity PA-19-074 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that examines the role of telomeres in wellness and disease, and to advance the incorporation of telomere studies into biobehavioral programs of research. A body of research has demonstrated the contribution of telomeres to health-related outcomes; however, additional studies are needed to achieve the full potential for incorporating telomere-guided approaches for maintaining wellness, reducing the risk and burden of disease, and for advancing symptom and self-management strategies.

Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional)

Tue, 2018-11-20 12:07
Funding Opportunity PA-19-073 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that examines the role of telomeres in wellness and disease, and to advance the incorporation of telomere studies into biobehavioral programs of research. A body of research has demonstrated the contribution of telomeres to health-related outcomes; however, additional studies are needed to achieve the full potential for incorporating telomere-guided approaches for maintaining wellness, reducing the risk and burden of disease, and for advancing symptom and self-management strategies.

Notice of Intent to Publish a Funding Opportunity Announcement for Research Evaluation and Commercialization Hubs (REACH) program

Tue, 2018-11-20 10:26
Notice NOT-OD-19-033 from the NIH Guide for Grants and Contracts

Data Science Research: Personal Health Libraries for Consumers and Patients (R01 Clinical Trial Optional)

Mon, 2018-11-19 11:01
Funding Opportunity PAR-19-072 from the NIH Guide for Grants and Contracts. The National Library of Medicine seeks applications for novel informatics and data science approaches that can help individuals gather, manage and use data and information about their personal health. A goal of this program is to advance research and application by patients and the research community through broadly sharing the results via publication, and through open source mechanisms for data or resource sharing.

Pages